Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) 物理性質
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 絵表示（GHS） |
|
| 注意喚起語 |
警告 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H302 |
飲み込むと有害 |
急性毒性、経口 |
4 |
警告 |
|
P264, P270, P301+P312, P330, P501 |
|
| 注意書き |
| P264 |
取扱い後は皮膚をよく洗うこと。 |
| P264 |
取扱い後は手や顔をよく洗うこと。 |
| P270 |
この製品を使用する時に、飲食または喫煙をしないこ と。 |
| P301+P312 |
飲み込んだ場合：気分が悪い時は医師に連絡する こと。 |
| P501 |
内容物/容器を．．．に廃棄すること。 |
|
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) 価格
もっと(4)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
Sigma-Aldrich Japan
|
Y0000738 |
European Pharmacopoeia (EP) Reference Standard
Flavoxate impurity B European Pharmacopoeia (EP) Reference Standard |
35888-94-9 |
y0000738 |
￥28300 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
PHR3592 |
certified reference material, pharmaceutical secondary standard
Flavoxate Related Compound C certified reference material, pharmaceutical secondary standard |
35888-94-9 |
40MG |
￥88400 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
1270731 |
United States Pharmacopeia (USP) Reference Standard
Flavoxate Related Compound C United States Pharmacopeia (USP) Reference Standard |
35888-94-9 |
20mg |
￥201000 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
Y0000738 |
European Pharmacopoeia (EP) Reference Standard
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) European Pharmacopoeia (EP) Reference Standard |
35888-94-9 |
|
￥35200 |
2021-03-23 |
購入 |
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) 化学特性,用途語,生産方法
使用
O-Desethylpiperidine Flavoxate Ethyl Ester is an impurity in the synthesis of Flavoxate (F373500), a smooth muscle relaxant. Used as antispasmodic; in treatment of urinary incontinence.
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) 上流と下流の製品情報
原材料
準備製品
Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester) 生産企業
Global( 20)Suppliers
35888-94-9()キーワード:
- 35888-94-9
- Flavoxate Related Compound C (20 mg) (3-Methylflavone-8-carboxylic acid ethyl ester)
- O-Desethylpiperidine Flavoxate Ethyl Ester
- Flavoxate Related CoMpound C
- Ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
- Flavoxate hydrochloride impurity C (EP)
- Ethyl 3-Methyl-4-oxo-2-phenyl-4H-1-
- 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, ethyl ester
- Flavoxate EP Impurity B
- Flavoxate Impurity 2 (Flavoxate EP Impurity B)
- Flavoxate EP Impurity B/ Flavoxate Related Compound C
- O-Desethylpiperidine Flavoxate Ethyl EsterQ: What is
O-Desethylpiperidine Flavoxate Ethyl Ester Q: What is the CAS Number of
O-Desethylpiperidine Flavoxate Ethyl Ester Q: What are the applications of
O-Desethylpiperidine Flavoxate Ethyl Ester
- Flavoxate Related Compound C (3-Methylflavone-8-carboxylic acid ethyl ester) (1270731)
- Flavoxate USP Related Compound C
- Flavoxate Hydrochloride Impurity B